Acumen Pharmaceuticals, Inc.

NasdaqGS:ABOS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 86.01 M

Share Price

USD 1.42

Avg Daily Volume

462,066

Change (1 day)

1.43%

Change (1 year)

-44.96%

Change (YTD)

-17.44%

Acumen Pharmaceuticals, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending August 17, 2025: N/A

Acumen Pharmaceuticals, Inc. Common Stock Issued is NA for the Trailing 12 Months (TTM) ending August 17, 2025. Common stock issued is cash received from issuing new shares of the company’s common stock.

Competitors

Eli Lilly and Company

USD 701.23

LLY

+16.80 2.46%

AbbVie Inc.

USD 206.69

ABBV

+2.01 0.98%

Roche Holding AG

USD 331.61

RO.SW

+7.43 2.29%

Novartis AG

USD 123.29

NOVN.SW

+1.51 1.24%

AstraZeneca PLC

USD 150.15

AZN.L

-2.01 -1.32%

Novo Nordisk A/S

USD 50.97

NOVO-B.CO

+0.44 0.87%

Merck & Co., Inc.

USD 84.21

MRK

+1.45 1.75%

Thermo Fisher Scientific Inc.

USD 489.01

TMO

+3.97 0.82%

Amgen Inc.

USD 296.47

AMGN

+6.18 2.13%

Gilead Sciences, Inc.

USD 118.37

GILD

-0.65 -0.55%

Pfizer Inc.

USD 25.14

PFE

+0.03 0.12%

Sanofi

USD 99.43

SAN.PA

+2.12 2.18%

Vertex Pharmaceuticals Incorporated

USD 392.79

VRTX

+2.49 0.64%

Bristol-Myers Squibb Company

USD 48.44

BMY

+0.63 1.32%

Chugai Pharmaceutical Co., Ltd.

USD 42.42

4519.T

+0.95 2.29%

View all

Key Data

Date	Common Stock Issued	Common Stock Repurchased	Free Cash Flow	Operating Cash Flow